Market Tracker

01/30 6:05pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

111.38
Data as of Jan 30
 -2.76 / -2.42%
Today’s Change
85.28
Today|||52-Week Range
116.66
+3.17%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

No recent news for SPDR® S&P Pharmaceuticals ETF.

Performance

1 month+2.65% 3 years+32.61%
3 months+5.01% 5 years+26.74%
1 year+27.31% Since inception+18.03%
Data through 01/31/2015

Quote Details

Previous close$114.14
Open day’s range111.21 – 114.25
Net asset value (NAV)111.32 (01/30/2015)
Daily volume119,190
Average volume (3 months)70,653
Data as of 3:59pm ET, 01/30/2015

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+26.74%+22.29%
Expense Gross exp ratio0.35%0.44%
Risk 5 year sharpe ratio1.641.44
Net assets$1.1B$1.5B
Average market cap$7.1B$34.2B
Average P/E28.625.1
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
SLXP Salix Pharmaceuticals Ltd3.24%
TTPH Tetraphase Pharmaceuticals Inc3.19%
PRGO Perrigo Co PLC3.17%
MDCO The Medicines Company3.17%
DEPO DepoMed Inc3.10%
MYL Mylan Inc3.08%
THRX Theravance Inc3.08%
ENDP Endo International PLC3.05%
MNK Mallinckrodt PLC3.04%
-- Auxilium Pharmaceuticals Inc3.02%